Sergiu Pașca

Overview

Sergiu Pașca is the Stanford psychiatry and neuroscience researcher interviewed by Andrew Huberman about human brain development, neurodevelopmental disorders, patient-derived stem-cell models, organoids, assembloids, transplantation, and therapeutic translation.

Current Profile

In the current source, Pașca addresses the inaccessibility and slow development of the human brain by reprogramming patient cells, guiding them into neural lineages, and assembling region-specific tissue into experimentally tractable circuits. His central case is Timothy syndrome, where a causal calcium-channel mutation provides a path from cellular phenotype to a nucleic-acid therapeutic. He pairs that optimism with explicit limits: behavioral diagnoses are heterogeneous, organoids are not miniature brains, cross-species models are incomplete, and unregulated stem-cell injections are not evidence-based autism treatment.

Key Characteristics

• Builds patient-derived human neural models to study development and disease mechanisms.
• Developed organoid and assembloid approaches for region-specific tissue, cell migration, and functional circuits.
• Uses rare genetic disorders as causal entry points into broader neurodevelopmental questions.
• Treats model-to-patient translation as a staged process requiring complementary validation.
• Rejects misleading “mini-brain” language and unsupported commercial stem-cell claims.
• Integrates science with prospective ethics, animal-welfare, nomenclature, and consent review.

Evidence

• Research program - Using Stem Cells to Cure Autism, Epilepsy & Schizophrenia | Dr. Sergiu Pașca describes induced pluripotent stem cells, long-lived neural organoids, multi-region assembloids, and transplantation studies.
• Translational case - Using Stem Cells to Cure Autism, Epilepsy & Schizophrenia | Dr. Sergiu Pașca follows Timothy syndrome across models toward a nucleic-acid therapeutic preparing for clinical testing.
• Evidence boundaries - Using Stem Cells to Cure Autism, Epilepsy & Schizophrenia | Dr. Sergiu Pașca distinguishes selected neural tissue models from whole brains and controlled research from unregulated injections.
• Governance - Using Stem Cells to Cure Autism, Epilepsy & Schizophrenia | Dr. Sergiu Pașca describes collaboration with ethics, law, religion, and social-science scholars.

Qualifications

This profile is bounded to one interview rather than a full biography or independent assessment of Pașca’s publications, patents, clinical program, or institutional roles. Technical milestones, rescue claims, training reach, and clinical timelines remain source-attributed.

What Changed

• Created a source-bounded profile connecting Pașca’s model-building, rare-disease, translation, and governance work.

Relationships

• Stanford University - institutional setting named for his research and ethics review.
• Andrew Huberman - interviewer developing the episode’s clinical and translational questions.
• Huberman Lab - podcast setting for the source.
• Human Neural Organoids and Assembloids - principal experimental platform described.
• Timothy Syndrome Therapy Translation - leading disease-to-treatment case.
• Autism Biological Heterogeneity - diagnostic and subgroup problem motivating causal models.